Differential effect of statins on diabetic nephropathy in db/db mice

  • Authors:
    • Yukinori Tamura
    • Toshinori Murayama
    • Manabu Minami
    • Masayuki Yokode
    • Hidenori Arai
  • View Affiliations

  • Published online on: August 10, 2011     https://doi.org/10.3892/ijmm.2011.769
  • Pages: 683-687
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Recent studies suggest a potential benefit of the lipid-lowering medication in the treatment of chronic kidney disease (CKD) such as diabetic nephropathy. Although statins have been widely used to lower serum cholesterol levels, the effect of these drugs on diabetic nephropathy has not been fully elucidated. In the present study, therefore, we addressed the role of different kinds of statins on diabetic nephropathy in db/db mice. Mice were fed with a standard diet with 0.005% (w/w) of pitavastatin, rosuvastatin, and pravastatin for 8 weeks starting from 8 weeks of age. The treatment with statins did not affect the food intake, body weight gain, adiposity, or blood pressure in db/db mice. Treatment with statins also had no effect on plasma lipid levels. In terms of the effect on albuminuria, pitavastatin and rosuvastatin reduced the urinary excretion of albumin by 60 and 40%, respectively, but not pravastatin, suggesting the effect of these two drugs on diabetic nephropathy. Furthermore, pitavastatin and rosuvastatin improved glomerular hypertrophy. All statins treatment improved insulin resistance. In addition, rosuvastatin and pravastatin treatment reduced oxidative stress measured by urinary 8-OHdG level, whereas the statins had no effect on the inflammatory response in the kidney of db/db mice. These results are not consistent with the renoprotective effect of statins. In conclusion, our data suggest that pitavastatin and rosuvastatin can improve diabetic nephropathy through the suppression of glomerular hypertrophy, independent of lipid-lowering or anti-oxidative effects.

Related Articles

Journal Cover

November 2011
Volume 28 Issue 5

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tamura Y, Murayama T, Minami M, Yokode M and Arai H: Differential effect of statins on diabetic nephropathy in db/db mice. Int J Mol Med 28: 683-687, 2011
APA
Tamura, Y., Murayama, T., Minami, M., Yokode, M., & Arai, H. (2011). Differential effect of statins on diabetic nephropathy in db/db mice. International Journal of Molecular Medicine, 28, 683-687. https://doi.org/10.3892/ijmm.2011.769
MLA
Tamura, Y., Murayama, T., Minami, M., Yokode, M., Arai, H."Differential effect of statins on diabetic nephropathy in db/db mice". International Journal of Molecular Medicine 28.5 (2011): 683-687.
Chicago
Tamura, Y., Murayama, T., Minami, M., Yokode, M., Arai, H."Differential effect of statins on diabetic nephropathy in db/db mice". International Journal of Molecular Medicine 28, no. 5 (2011): 683-687. https://doi.org/10.3892/ijmm.2011.769